immunotherapy

Open Access
Expression Patterns of T-cell immunoreceptor With Ig and ITIM domains (TIGIT) in Classical Hodgkin Lymphoma: A Clinicopathological Study
ALEXANDRA PAPOUDOU-BAI, GEORGIA KARPATHIOU, EPAMEINONDAS KOUMPIS, MICHEL PEOC’H, ELEFTHERIA HATZIMICHAEL and PANAGIOTIS KANAVAROS

In Vivo May 2026, 40 (3) 1707-1714; DOI: https://doi.org/10.21873/invivo.14321
Open Access
The Prognostic Role of Baseline and Early Dynamics of Peripheral Blood Cell Ratios in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab
ONDREJ FIALA, MICHAELA TKADLECOVA, JINDRICH KOPECKY, PETR HOSEK, HANA STUDENTOVA, MICHAL VOCKA, MARTIN MATEJU, RADKA LOHYNSKA, DOMINIKA SIKOVA, PETR STRANSKY, RADEK KUCERA, ANEZKA ZEMANKOVA, MARTINA SPISAROVA, PETER PRIESTER, JAN KOURIL, TOMAS BUCHLER, LUCIE GRMELOVA, BOHUSLAV MELICHAR and ALEXANDR POPRACH

In Vivo March 2026, 40 (2) 1065-1079; DOI: https://doi.org/10.21873/invivo.14261
Open Access
Methionine Restriction Alone Induces T-cell-mediated Immunotherapy of Osteosarcoma in a Syngeneic Mouse Model
KOHEI MIZUTA, YUTARO KUBOTA, YUSUKE AOKI, SEI MORINAGA, YOHEI ASANO, YUTA MIYASHI, MICHAEL BOUVET, YASUNORI TOME, KOTARO NISHIDA and ROBERT M. HOFFMAN

In Vivo March 2026, 40 (2) 813-825; DOI: https://doi.org/10.21873/invivo.14239
Open Access
Onset and Outcomes of Immune-related Adverse Events in Genitourinary Cancer Treated With Immune Checkpoint Inhibitors
MINORU KATO, SHOMA YAMAMOTO, TAISUKE MATSUE, NAO YUKIMATSU, TAIYO OTOSHI, TAKESHI YAMASAKI, HIROYASU KANEDA, MASAFUMI KURAJOH, ASAHIRO ITO, NAOSHI ODAGIRI, AKINOBU NAKATA, AIKO KOBAYASHI, KATSUYUKI KURATSUKURI and JUNJI UCHIDA

In Vivo March 2026, 40 (2) 980-991; DOI: https://doi.org/10.21873/invivo.14254
Open Access
Up-regulation of Cuproptosis-related lncRNAS in Patients Receiving Immunotherapy for Metastatic Clear Cell Renal Cell Carcinoma Indicates Progressive Disease
HECTOR KATIFELIS, STAMATIKI GRAMMATIKAKI, ROUBINI ZAKOPOULOU, ARISTOTELIS BAMIAS, MICHALIS V. KARAMOUZIS, KONSTANTINOS STRAVODIMOS and MARIA GAZOULI

In Vivo January 2025, 39 (1) 146-151; DOI: https://doi.org/10.21873/invivo.13812
Open Access
A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF Mutation
ALFREDO COLOMBO, PORRETTO MARIA CONCETTA, VITTORIO GEBBIA, DANIELA SAMBATARO, GIUSEPPINA SCANDURRA and MARIA ROSARIA VALERIO

In Vivo January 2025, 39 (1) 25-36; DOI: https://doi.org/10.21873/invivo.13802
Open Access
Systemic Scleroderma Induced by Nivolumab in Malignant Melanoma
THIBAUD LOUPRET, ROMAIN BOISSEAU, JEAN-GUILLAUME LOPEZ, PHILIPPE BERTIN and PASCALE VERGNE-SALLE

In Vivo May 2024, 38 (3) 1451-1453; DOI: https://doi.org/10.21873/invivo.13589
Open Access
Association of Nutritional Indices With Adverse Effects and Time-to-Treatment-Failure in Triple Therapy for Lung Cancer
YASUHISA HASHINO, TAKUMU MATUSHITA, TAE HATSUYAMA, AZUSA WAKAMOTO, KEISUKE GOTO, TAKANOBU HOSHI, KUNINORI IWAYAMA, KOICHI OHTAKI, TAKAKI TODA and HIDEKI SATO

In Vivo March 2024, 38 (2) 864-872; DOI: https://doi.org/10.21873/invivo.13512
Open Access
Association of Geriatric Nutritional Risk Index With Immune Checkpoint Inhibitor Treatment Duration and Adverse Events in Lung Cancer
ATSUYA SHIMIZU, MIYU FUKASAWA, KOHARU MITANI, KEISUKE GOTO, AZUSA WAKAMOTO, TAE HATSUYAMA, TAKANOBU HOSHI, ISAO HASEGAWA and HIDEKI SATO

In Vivo January 2024, 38 (1) 418-424; DOI: https://doi.org/10.21873/invivo.13454
Open Access
Immunotherapy for Unresectable Small Bowel Adenocarcinoma: A Case Series
KEIJI SUGIYAMA, SEIRA OWAKI, MARIKO SATO, KAZUHIRO SHIRAISHI, KYOKO KATO and CHIYOE KITAGAWA

In Vivo January 2024, 38 (1) 518-522; DOI: https://doi.org/10.21873/invivo.13469

Main menu

User menu

Search

immunotherapy

Pages